All In MedTech

Company

Syncardia Systems

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$11.4M

2 Form D offerings, 2011 to 2014

Equity

$11.4M

Stock sold for cash

Debt and convertible notes

$0

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $6.4M raised of $15.0M sought, first sale Sep 15, 2014, 83 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Sep 15, 2014Equity$6.4M$15.0M83Rule 506(b)Form D ↗Oct 14, 2014

1 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
SYNCARDIA SYSTEMS INC
Headquarters
Tucson, Arizona
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    10 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is free with an account

    For Syncardia Systems we have 1 government grant totalling $606K.

    Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

    Latest FDA decisions

    Search the Clearance Tracker

    No 510(k), De Novo or PMA decisions under this name since 2015.

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT02232659 · 38 participants (planned) · Start Feb 2016 · Primary completion Dec 2021

      Device: 70cc TAH-t for Destination Therapy · For: Life-threatening; Biventricular Heart Failure; Ineligible for Cardiac Transplant

      Sites: Phoenix, Arizona; Tucson, Arizona; Los Angeles, California · 7 sites in all

    4 more trials with a free account

    Reports received

    183

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    153

    84% of reports

    Injury reports

    5

    2.7% of reports

    Death reports

    25

    14% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 238030
    Jan 243010
    Feb 248010
    Mar 245030
    Apr 244010
    May 246010
    Jun 249010
    Jul 243010
    Aug 2410000
    Sep 246010
    Oct 243030
    Nov 243010
    Dec 244020
    Jan 259010
    Feb 254010
    Mar 255000
    Apr 250000
    May 250000
    Jun 256000
    Jul 251000
    Aug 255000
    Sep 253000
    Oct 253000
    Nov 250000
    Dec 258100
    Jan 260000
    Feb 269000
    Mar 263000
    Apr 260000
    May 260010
    Jun 260000
    Jul 2621130
    Aug 26122210
    Sep 2658100
    Oct 2642000
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    4 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.